 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.
| 6. | Barbara M Davit, Patrick E Nwakama, Gary J Buehler, Dale P Conner, Sam H Haidar, Devvrat T Patel, Yongsheng Yang, Lawrence X Yu, Janet Woodcock | ||
|
|
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration | |
|---|---|---|---|
|
|
Oct 01, 2009; 43: 1583-1597.
(In "BIOEQUIVALENCE") |
|
|
|
||
| 7. | Alicia R Desilets, Sushmita Dhakal-Karki, Kaelen C Dunican | ||
|
|
Role of Metformin for Weight Management in Patients Without Type 2 Diabetes | |
|
|
Jun 01, 2008; 42: 817-826.
(In "OBESITY") |
|
|
|
||
| 8. | A Janelle Hermosillo, Sarah A Spinler | ||
|
|
Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous? | |
|
|
Jun 01, 2008; 42: 790-805.
(In "THERAPEUTIC CONTROVERSIES") |
|
|
|
||
| 9. | Chris Marrone | ||
|
|
NDCR 2009: New Drugs 2002–2008, Advantages/Disadvantages and New Drug Comparison Ratings [NDCR]: By Daniel A Hussar BS MS PhD. Published by Moore Road Press, King of Prussia, PA, 2009. ISBN 978-1441448675. Paperbound, xii + 336 pp. (25.5 x 20.5 cm), $34.95. www.NewDrugsNDCR.com | |
|
|
Oct 01, 2009; 43: 1729-1730.
(In "NEW PUBLICATIONS") |
|
|
|
||
| 10. | Shawn D Anderson, John G Gums | ||
|
|
Ceftobiprole: An Extended-Spectrum Anti–Methicillin-Resistant Staphylococcus aureus Cephalosporin | |
|
|
Jun 01, 2008; 42: 806-816.
(In "NEW DRUG DEVELOPMENTS") |
|
|
|
||
| [Previous 5 Articles] [Next 5 Articles] | |||
= from the current issue
Last Updated: 11/09/2009 05:43:53
 |
 |
 |
 |
 |
 |
 |